维普中文期刊产品整合服务
27篇 您的检索式:作者名="Verma AR"
    题名 作者 年代 出处 被引量
1Development of matrix controlled transdermal delivery systems of pentazocine: In vitro/in vivo performance 显示文摘Verma PRP Chandak AR 2009Acta Phannaceut2009,59,2:1
2Development of matrix controlled transdermal delivery systems of pentazocine:In vitro/ in vivo performance 显示文摘Prasad verma PR Chandak AR 2009Acta Pharm2009,59,2:1
3Development of matrix controlledtransdermal delivery systems of pentazocine: Invitro/invivoperformance显示文摘Prasad Verma PR Chandak AR 2009Acta Pharm2009,59,2:1
4Development of matrix controlledtransdermal delivery systems of pentazocine:In vitro/in vivo perfor-mance 显示文摘Prasad Verma PR Chandak AR 2009Acta Pharm2009,59,2:1
5Development of matrix controlled transdermal delivery systems of pentazocine: in vitroin vivo performance显示文摘Prasad Verma PR Chandak AR 2009Acta Pharm2009,59,20:1
6Development of matrix controlled transdermal delivery systems of pentazocine: In vitro/in vivo per-ormance 显示文摘Prasad Verma PR Chandak AR 2009Acta Pharm2009,59,2:1
7Development of matrix controlled transdermaldelivery systems of pentazocine:in vitro/in vivo performance 显示文摘Prasad Verma PR Chandak AR 2009Acta Pharm2009,59,2:1
8Evaluating steatosis in pancre- atic transplant显示文摘Verma AR Papalois V 2011Exp Clin Transplant2011,9,3:1
9Development ofmatrix controlled transdermal delivery systems of pentazocine: In vitro/ in vivo performance 显示文摘PRASAD VERMA PR CHANDAK AR 2009Acta Pharm2009,59,2:1
10Bone marrow progeni-tor cell therapy-mediated paracrine regulation of cardiac miR-NA-155 modulates fibrotic response in diabetic hearts 显示文摘Kishore R Verma SK Mackie AR 2013PLoS One2013,8,60:1
11Bone marrow progenitorcell therapy-mediated paracrine regulation of cardiac miRNA-155modulates fibrotic response in diabetic hearts 显示文摘Kishore R Verma SK Mackie AR 2013PLoS One2013,8,60:1
12In vitro and in vivo antioxidant properties of different fractions of Moringa oleifera leaves显示文摘Verma AR Vijayakumar M Mathela CS 2009Food and Chemical Toxicology2009,47,9:1
13Development of matrix controlled transdermal delivery systems of pentazocine: In vitro/ in vivo performance 显示文摘PRASAD VERMA PR CHANDAK AR 2009Acta Pharm2009,59,2:1
14Development of matrix con-trolled transdermal delivery systems of pentazocine : In vitro/invi-vo performance 显示文摘Prasad Verma PR Chandak AR 2009Acta Pharm2009,59,2:1
15Bone marrow pro- genitor cell therapy-mediated paracrine regulation of car- diac miRNA-155 modulates fi brotic response in diabetic hearts显示文摘Kishore R Verma SK Mackie AR 2013PLoS One2013,8,60:1
16Development of matrix controlled transdermal delivery systems of pentazocine:In vitro/in vivo perfor- mance显示文摘Prasad verma PR Chandak AR 2009Acta Pharm2009,59,2:1
17Development of matrix controlled transdennal delivery systems of pentazocine : In vitro/in vivo performance显示文摘Prasad Verma PR Chandek AR 2009Acta Pharm2009,59,2:1
18Increased atherogcnesis during Streptococcus mutans infection in ApoE-null mice显示文摘Kesavalu L Lucas AR Verma RK 2012J Dent Res2012,91,3:1
19Human leucocyte interferon preparation-mediated block of granulopoietic differentiation in vitro显示文摘Verma DS Spitzer G Zander AR 1981Exp Hematol1981,9,1:1
20Development of matrix controlled trans- dermal delivery systems of pentazocine: In vitro/in vivo performance 显示文摘Prasad verma PR Chandak AR 2009Acta Pharm2009,59,2:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费